SEATTLE & CHICAGO--(BUSINESS WIRE)--NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that it has expanded the capabilities of its nCounter Elements™ General Purpose Reagents (GPRs) with the addition of a universal junction probe design that offers specific detection and analysis of known fusion genes. The company announced the availability of the new design capability to early access customers at the 2014 American Association for Clinical Chemistry annual meeting in Chicago.
Help employers find you! Check out all the jobs and post your resume.
